UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Peanut-Induced Anaphylaxis · Peanut Allergy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Contact: Study coordinator (Alex Stoyanov, MD) · Alex.Stoyanov@health.nsw.gov.au · (02) 9515 7585
Flinders Medical Center, Bedford Park, South Australia, Australia
Contact: Study coordinator (Syed Ali, MD) · Health.ResearchHubCT@sa.gov.au
The Royal Melbourne Hospital, Fitzroy, Victoria, Australia
Contact: Study coordinator (Kymble Spriggs) · AllergyResearch@mh.org.au · 03 9342 7000
Fiona Stanley Hospital, Perth, Western Australia, Australia
Contact: Study coordinator (Michael O Sullivan, MD) · fshimmunology.research@health.wa.gov.au · 08 6456 2222
Pacific Clinical Research Network - Auckland, Takapuna, Auckland, New Zealand
Contact: Study coordinator (Enrollment Coordinator) · Auckland@pcrn.co.nz · +64 9 242 3321

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

Allergy, Peanut · Peanut Allergy · Peanut Hypersensitivity

Abroad (travel likely)RecruitingPHASE2

Boston, United States